Updated: Dec 9, 2025

Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
Monica M Matsumoto1, Ashley Altman2, Balaji Jothishankar1,3
1Department of Radiology, Pritzker School of Medicine, University of Chicago, 924 E 57th St, Ste 104, Chicago, IL 60637.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Prebiopsy lab testing for abnormal coagulation (INR) or platelet counts is rarely necessary for patients without bleeding risks undergoing percutaneous biopsies. Eliminating this routine testing can significantly reduce healthcare costs and save time for both physicians and patients.
Failed At:
2026-07-10T15:05:47.462570+00:00